US stocks rose on Friday as traders weighed another record in daily virus cases against advances in treatment. On Thursday, the US reported 63,200 new coronavirus cases, according to data from Johns Hopkins University. Meanwhile, Gilead Sciences said on Friday that an analysis of clinical-trial data for its remdesivir drug found a 62% reduction in mortality risk among severe COVID-19 patients. Oil rose as the International Energy Agency said the increase in coronavirus cases could hurt the...
Continue Reading Dow gains 250 points as traders weigh virus spike against treatment advances